Risks of Opioids in ST-Elevation Myocardial Infarction: A Review

被引：5

作者：

Tavenier, Anne Henrieke ^{[1
]}

Hermanides, Renicus Suffridus ^{[1
]}

Ottervanger, Jan Paul ^{[1
]}

Ter Horst, Peter Gerrit Johannes ^{[2
]}

Kedhi, Elvin ^{[1
]}

van't Hof, Adriaan W. J. ^{[3
,4
]}

机构：

[1] Isala, Dept Cardiol, Dr van Heesweg 2, NL-8025 AB Zwolle, Netherlands

[2] Isala, Dept Clin Pharm, Zwolle, Netherlands

[3] Maastricht Univ, Dept Cardiol, Med Ctr, Maastricht, Netherlands

[4] Zuyderland Med Ctr, Dept Cardiol, Heerlen, Netherlands

来源：

DRUG SAFETY | 2018年 / 41卷 / 12期

关键词：

PERCUTANEOUS CORONARY INTERVENTION; PLATELET INHIBITION; MORPHINE USE; SEGMENT ELEVATION; TABLETS; PAIN; ACETAMINOPHEN; REMIFENTANIL; AGGREGATION; ASSOCIATION;

D O I：

10.1007/s40264-018-0710-y

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Although opioids are recommended and frequently used in the acute phase of ST-elevation myocardial infarction (STEMI), their use is accompanied by serious side effects. In particular, gastrointestinal adverse effects may disturb absorption of essential oral medication like platelet inhibitors. This may cause suboptimal platelet inhibition and increased risk of acute stent thrombosis. Some clinical studies have already demonstrated these negative results. Alternative strategies to optimize platelet inhibition and pain relief in STEMI are being investigated. Clinicians should become more aware of the potential side effects of opioids in STEMI.

引用

页码：1303 / 1308

页数：6

共 50 条

[1] Risks of Opioids in ST-Elevation Myocardial Infarction: A Review
Anne Henrieke Tavenier
Renicus Suffridus Hermanides
Jan Paul Ottervanger
Peter Gerrit Johannes Ter Horst
Elvin Kedhi
Adriaan W. J. van ‘t Hof
Drug Safety, 2018, 41 : 1303 - 1308
[2] Opioids and ST Elevation Myocardial Infarction: A Systematic Review
Koh, Ji Quan Samuel
Fernando, Himawan
Peter, Karlheinz
Stub, Dion
HEART LUNG AND CIRCULATION, 2019, 28 (05): : 697 - 706
[3] ST-elevation no myocardial infarction
Peter Damman
Robbert J. de Winter
Mitchell W. Krucoff
Journal of Thrombosis and Thrombolysis, 2017, 43 : 426 - 427
[4] ST-elevation no myocardial infarction
Damman, Peter
de Winter, Robbert J.
Krucoff, Mitchell W.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2017, 43 (03) : 426 - 427
[5] Biomarkers and ST-elevation myocardial infarction
Mueller, Christian
HEART, 2013, 99 (16) : 1143 - 1143
[6] Diagnosis of ST-Elevation Myocardial Infarction
Wadas, Theresa
JNP-JOURNAL FOR NURSE PRACTITIONERS, 2013, 9 (02): : 124 - 125
[7] Treatment of ST-elevation myocardial infarction
Hermanides, Rik
Ottervanger, Jan Paul
FUTURE CARDIOLOGY, 2008, 4 (04) : 391 - 397
[8] ST-Elevation Myocardial Infarction Track
Abella, Benjamin S.
Otterspoor, Luuk
Nichol, Graham
Martin, Jack L.
THERAPEUTIC HYPOTHERMIA AND TEMPERATURE MANAGEMENT, 2021, 11 (02) : 65 - 70
[9] Ticagrelor in ST-Elevation Myocardial Infarction
Sgueglia, Gregory A.
Tarantini, Giuseppe
Niccoli, Giampaolo
CURRENT VASCULAR PHARMACOLOGY, 2012, 10 (04) : 458 - 462
[10] Clopidogrel in ST-elevation myocardial infarction
Sabatine, Marc S.
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2006, 8 (0G) : G31 - G34

← 1 2 3 4 5 →